These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 3670332)

  • 1. Methapyrilene is a genotoxic carcinogen: studies on methapyrilene and pyrilamine in the L5178Y/TK +/- mouse lymphoma assay.
    Turner NT; Woolley JL; Hozier JC; Sawyer JR; Clive D
    Mutat Res; 1987 Nov; 189(3):285-97. PubMed ID: 3670332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procarbazine is a potent mutagen at the heterozygous thymidine kinase (tk +/-) locus of mouse lymphoma assay.
    Clive D; Turner N; Krehl R
    Mutagenesis; 1988 Mar; 3(2):83-7. PubMed ID: 3288842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potent hepatocarcinogen methapyrilene induces mutations in L5178Y mouse lymphoma cells in the apparent absence of DNA adduct formation.
    Casciano DA; Talaska G; Clive D
    Mutat Res; 1991 Jun; 263(2):127-32. PubMed ID: 2046705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of methapyrilene for bacterial mutation with metabolic activation by Aroclor-induced, methapyrilene-induced and noninduced rat-liver S9.
    Oberly TJ; Scheuring JC; Richardson KA; Richardson FC; Garriott ML
    Mutat Res; 1993 Apr; 299(2):77-84. PubMed ID: 7680426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP Hepatotoxicity Studies of the Liver Carcinogen Methapyrilene Hydrochloride (CAS No. 135-23-9) Administered in Feed to Male F344/N Rats.
    Toxic Rep Ser; 2000 Feb; 46():1-C7. PubMed ID: 11986676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity and clastogenicity of proflavin in L5178Y/TK +/- -3.7.2.C cells.
    DeMarini DM; Brock KH; Doerr CL; Moore MM
    Mutat Res; 1988 Feb; 204(2):323-8. PubMed ID: 3343981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotoxicity of 6 oxime compounds in the salmonella/mammalian-microsome assay and mouse lymphoma TK +/- assay.
    Rogers-Back AM; Lawlor TE; Cameron TP; Dunkel VC
    Mutat Res; 1988 Feb; 204(2):149-62. PubMed ID: 3278206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity of rat-liver S9 to L5178Y mouse lymphoma cells.
    Myhr BC; Mayo JK
    Mutat Res; 1987 Sep; 189(1):27-37. PubMed ID: 3627149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxicity, toxicity, and carcinogenicity of the antihistamine methapyrilene.
    Mirsalis JC
    Mutat Res; 1987 May; 185(3):309-17. PubMed ID: 3553919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant frequencies and loss of heterozygosity induced by N-ethyl-N-nitrosourea in the thymidine kinase gene of L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.
    Chen T; Harrington-Brock K; Moore MM
    Mutagenesis; 2002 Mar; 17(2):105-9. PubMed ID: 11880538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic evaluation of carcinogens and non-carcinogens in the L5178Y/TK assay utilizing postmitochondrial fractions (S9) from normal rat liver.
    Amacher DE; Turner GN
    Mutat Res; 1982 Feb; 97(1):49-65. PubMed ID: 7057798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic analysis of the L5178Y/TK+/- leads to TK-/- mouse lymphoma mutagenesis assay system.
    Hozier J; Sawyer J; Moore M; Howard B; Clive D
    Mutat Res; 1981 Nov; 84(1):169-81. PubMed ID: 7329431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenicity of three disinfection by-products: di- and trichloroacetic acid and chloral hydrate in L5178Y/TK +/- (-)3.7.2C mouse lymphoma cells.
    Harrington-Brock K; Doerr CL; Moore MM
    Mutat Res; 1998 Mar; 413(3):265-76. PubMed ID: 9651541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK +/- -3.7.2C mouse lymphoma cells.
    DeMarini DM; Brock KH; Doerr CL; Moore MM
    Mutat Res; 1987 Mar; 187(3):141-9. PubMed ID: 3821767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of chromosome aberration frequency and small-colony TK-deficient mutant frequency in L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.
    Moore MM; Doerr CL
    Mutagenesis; 1990 Nov; 5(6):609-14. PubMed ID: 2263219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the mouse lymphoma tk assay (microwell method) as an alternative to the in vitro chromosomal aberration test.
    Honma M; Hayashi M; Shimada H; Tanaka N; Wakuri S; Awogi T; Yamamoto KI; Kodani N; Nishi Y; Nakadate M; Sofuni T
    Mutagenesis; 1999 Jan; 14(1):5-22. PubMed ID: 10474816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the activities of benzo[a]pyrene, benzidine and ethyl methanesulphonate in the L5178Y TK +/- mouse lymphoma mutagenicity assay using standardized and non-standardized protocols.
    Riach CG; Cattanach PJ; Howgate S; Shepherd W; McBride D; Edwards IW; McGregor DB; Combes RD
    Mutagenesis; 1990; 5 Suppl():35-44. PubMed ID: 2184319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical mutagenesis at the thymidine kinase locus in L5178Y mouse lymphoma cells: results for 31 coded compounds in the National Toxicology Program.
    Myhr BC; Caspary WJ
    Environ Mol Mutagen; 1991; 18(1):51-83. PubMed ID: 1864269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide: lack of mutagenic activity across phyla and genetic endpoints.
    Ashby J; Tinwell H; Callander RD; Kimber I; Clay P; Galloway SM; Hill RB; Greenwood SK; Gaulden ME; Ferguson MJ; Vogel E; Nivard M; Parry JM; Williamson J
    Mutat Res; 1997 Dec; 396(1-2):45-64. PubMed ID: 9434859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular aspects of chemical mutagenesis in L5178Y/tk +/- mouse lymphoma cells.
    Clive D; Glover P; Applegate M; Hozier J
    Mutagenesis; 1990 Mar; 5(2):191-7. PubMed ID: 2188074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.